SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (20815)4/19/1999 7:15:00 PM
From: VLAD  Respond to of 23519
 
martin,

IMHO the Street is really missing what is cooking on the R&D front for Vivus. The femme cream alone can easily bring in a couple bucks a share in earnings once it is out on the market.

I hope that come our cc on Wed. Vivus is smart enough to have a name for the product etc...



To: Mkilloran who wrote (20815)4/20/1999 7:20:00 AM
From: betty moyers  Respond to of 23519
 
Mkilloran, I totally concur. Double digits by July. I want the stock to work and struggle there. The further up we go slowly and with effort the higher she will go when she blows.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News